- Home
- SWBI vs ORIC Comparison
SWBI vs ORIC Comparison
Compare SWBI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWBI
- ORIC
- Stock Information
- Founded
- SWBI 1852
- ORIC 2014
- Country
- SWBI United States
- ORIC United States
- Employees
- SWBI N/A
- ORIC N/A
- Industry
- SWBI Ordnance And Accessories
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- SWBI Industrials
- ORIC Health Care
- Exchange
- SWBI Nasdaq
- ORIC Nasdaq
- Market Cap
- SWBI 587.1M
- ORIC 633.7M
- IPO Year
- SWBI N/A
- ORIC 2020
- Fundamental
- Price
- SWBI $13.37
- ORIC $9.59
- Analyst Decision
- SWBI Strong Buy
- ORIC Strong Buy
- Analyst Count
- SWBI 2
- ORIC 9
- Target Price
- SWBI $18.00
- ORIC $18.75
- AVG Volume (30 Days)
- SWBI 503.0K
- ORIC 498.9K
- Earning Date
- SWBI 12-05-2024
- ORIC 11-12-2024
- Dividend Yield
- SWBI 3.89%
- ORIC N/A
- EPS Growth
- SWBI N/A
- ORIC N/A
- EPS
- SWBI 0.75
- ORIC N/A
- Revenue
- SWBI $509,924,000.00
- ORIC N/A
- Revenue This Year
- SWBI $6.69
- ORIC N/A
- Revenue Next Year
- SWBI $6.31
- ORIC N/A
- P/E Ratio
- SWBI $17.93
- ORIC N/A
- Revenue Growth
- SWBI 0.16
- ORIC N/A
- 52 Week Low
- SWBI $11.96
- ORIC $6.33
- 52 Week High
- SWBI $18.05
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- SWBI 52.82
- ORIC 52.76
- Support Level
- SWBI $12.87
- ORIC $8.11
- Resistance Level
- SWBI $13.22
- ORIC $8.90
- Average True Range (ATR)
- SWBI 0.43
- ORIC 0.74
- MACD
- SWBI 0.00
- ORIC -0.04
- Stochastic Oscillator
- SWBI 60.54
- ORIC 49.42
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.